|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IMNM
|
Immunome, Inc.
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
US
|
NASDAQ
|
|
IPA
|
ImmunoPrecise Antibodies Ltd.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
KDNY
|
Chinook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
NAVB
|
Navidea Biopharmaceuticals, Inc.
|
US
|
AMEX
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OTLK
|
Outlook Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
US
|
NASDAQ
|
|
RGEN
|
Repligen Corporation
|
US
|
NASDAQ
|
|
RZLT
|
Rezolute, Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|